← Leaderboards
Kevin Ka Wang Wang
Morehouse School Of Medicine
$8,227,153
Attributed
$11,724,593
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,724,593 · 9
VA$0 · 3
By mechanism
U01$5,018,034 · 2
RF1$2,283,334 · 1
R01$1,871,476 · 1
UH3$1,143,333 · 1
UG3$758,109 · 1
R21$397,300 · 1
Top collaborators
- Geoffrey T Manley4 shared
- Ramon R Diaz-Arrastia2 shared
- Jamie Sanders Hutchison2 shared
- Stefania Mondello2 shared
- Ava M. Puccio2 shared
- Cheryl Lea Wellington2 shared
Others in their field
Top investigators on “Injury”
- Polly Chang · Sri International$119,352,977
- Marco Pahor · Wake Forest University Health Sciences$82,312,292
- Kerry J Kelly · New York City Fire Department$81,924,266
- Asrar B. Malik · University Of Illinois At Chicago$81,164,529
- Peter Scott Heeger · Case Western Reserve University$76,259,223
- Jacqueline Moline · Icahn School Of Medicine At Mount Sinai$75,762,106
Research focus
InjuryBrainTraumatic Brain InjuryTau ProteinsSamplingBiological MarkersProteinsPathologicSerumFutureChronicGlial Fibrillary Acidic ProteinClinical ResearchBaseMild Traumatic Brain InjuryDiagnosisEnzyme-Linked Immunosorbent AssayNerve DegenerationAnimalsInterestAffectNeuronsTau-1Brain Region
Grant awards (34)
Analytical characterization and validation of blood-biomarkers for monitoring TBI evolution$1,520,962
U01 · FY2025 · NS
Persistent Pre- and Post-Synaptic Changes After Moderate Traumatic Brain Injury and Mitigation with MitoQ$0
I01 · FY2025 · VA · contact PI
TBI-ADRD Modeling with a Team Science Approach (TBI-ADRD Team Science)$2,283,334
RF1 · FY2024 · NS · contact PI
Analytical characterization and validation of blood-biomarkers for monitoring TBI evolution$1,444,308
U01 · FY2024 · NS
Analytical Validation of Tau and P-Tau as acute and subacute prognostic biomarkers for complicated mild TBI$471,118
U01 · FY2024 · NS · contact PI
Persistent Pre- and Post-Synaptic Changes After Moderate Traumatic Brain Injury and Mitigation with MitoQ$0
I01 · FY2024 · VA · contact PI
Analytical Validation of Tau and P-Tau as acute and subacute prognostic biomarkers for complicated mild TBI$510,932
U01 · FY2023 · NS · contact PI
NIBA-TBI: Neuro-Imaging and biofluid-based Biomarker Assessments as translational pathophysiological outcome measures in TBI$356,607
UH3 · FY2023 · NS · contact PI
Persistent Pre- and Post-Synaptic Changes After Moderate Traumatic Brain Injury and Mitigation with MitoQ$0
I01 · FY2023 · VA · contact PI
Mild Traumatic Brain Injury and Opiate Exposure Crosstalk: Neuropathological, Neurobehavioral, and Neuroproteomic Assessments$0
I21 · FY2022 · VA · contact PI
Analytical Validation of Tau and P-Tau as acute and subacute prognostic biomarkers for complicated mild TBI$525,553
U01 · FY2021 · NS · contact PI
NIBA-TBI: Neuro-Imaging and biofluid-based Biomarker Assessments as translational pathophysiological outcome measures in TBI$390,337
UH3 · FY2021 · NS · contact PI
Mild Traumatic Brain Injury and Opiate Exposure Crosstalk: Neuropathological, Neurobehavioral, and Neuroproteomic Assessments$0
I21 · FY2021 · VA · contact PI
Analytical Validation of Tau and P-Tau as acute and subacute prognostic biomarkers for complicated mild TBI$545,161
U01 · FY2020 · NS · contact PI
NIBA-TBI: Neuro-Imaging and biofluid-based Biomarker Assessments as translational pathophysiological outcome measures in TBI$396,389
UH3 · FY2020 · NS · contact PI
Repetitive mTBI-induced neurobehavioral changes and CTE-like proteinopathy$0
I01 · FY2020 · VA · contact PI
Mild Traumatic Brain Injury and Opiate Exposure Crosstalk: Neuropathological, Neurobehavioral, and Neuroproteomic Assessments$0
I21 · FY2020 · VA · contact PI
Repetitive mTBI-induced neurobehavioral changes and CTE-like proteinopathy$0
I01 · FY2020 · VA · contact PI
NIBA-TBI: Neuro-Imaging and biofluid-based Biomarker Assessments as translational pathophysiological outcome measures in TBI$361,569
UG3 · FY2019 · NS · contact PI
Administrative Supplement to 1 UG3 NS106938-02: âNIBA-TBI: Neuro-Imaging and biofluid-based Biomarker Assessments as translational pathophysiological outcome measures in TBI$22,646
UG3 · FY2019 · NS · contact PI
Repetitive mTBI-induced neurobehavioral changes and CTE-like proteinopathy$0
I01 · FY2019 · VA · contact PI
NIBA-TBI: Neuro-Imaging and biofluid-based Biomarker Assessments as translational pathophysiological outcome measures in TBI$373,894
UG3 · FY2018 · NS · contact PI
Repetitive mTBI-induced neurobehavioral changes and CTE-like proteinopathy$0
I01 · FY2018 · VA · contact PI
Repetitive mTBI-induced neurobehavioral changes and CTE-like proteinopathy$0
I01 · FY2016 · VA · contact PI
Elucidate Consequences of Autoimmune Response to Protease-modified GFAP in TBI$187,500
R21 · FY2015 · NS · contact PI
Elucidate Consequences of Autoimmune Response to Protease-modified GFAP in TBI$209,800
R21 · FY2014 · NS · contact PI
The National Neurotrauma Society 30th Annual Conference (Phoenix July 22-25,2012)$25,000
R13 · FY2012 · NS · contact PI
Biochemical Basis of Axonal & Myelin Injury In Head Trauma$441,401
R01 · FY2008 · NS · contact PI
Development of Novel Biomarkers for Traumatic Brain injury$228,007
R44 · FY2008 · NS · contact PI
Biochemical Basis of Axonal & Myelin Injury In Head Trauma$326,474
R01 · FY2007 · NS · contact PI
Biochemical Basis of Axonal & Myelin Injury In Head Trauma$136,056
R01 · FY2007 · NS · contact PI
Biochem. Basis of Axonal & Myelin Injury In Head Trauma$449,667
R01 · FY2006 · NS · contact PI
Biochem. Basis of Axonal & Myelin Injury In Head Trauma$38,560
R01 · FY2006 · NS · contact PI
Biochem. Basis of Axonal &Myelin Injury In Head Trauma$479,318
R01 · FY2005 · NS